Results 221 to 230 of about 188,451 (293)

CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.

Journal of Clinical Investigation, 2012
C. Schürch, C. Riether, M. Matter, A. Tzankov, A. Ochsenbein   +4 more
semanticscholar   +1 more source

Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]

, 2008
Jimenez, Sergio A., Rosenbloom, Joel
core   +1 more source

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

Journal of Clinical Investigation, 2000
B. Druker, N. Lydon
semanticscholar   +1 more source

Mutation of the N-ras Gene in a Patient Suffering from the Blast Phase of Chronic Myelogenous Leukemia [PDF]

, 2009
Sung-Heon Song, Young-Wook Roh, Yong‐Woo Ahn, Yeonjae Kim, Young-Sang Byoun, Jiyoung Choi, Deok-Won Hwang, Byoung-Bae Park, Jung-Hye Choi, In-Soon Kim, Byoung-Kook Kim, Young-Yiul Lee   +11 more
openalex   +1 more source

STUDIES ON THE LONG-TERM SURVIVORS IN CHRONIC MYELOGENOUS LEUKEMIA AND THE CHEMOTHERAPY OF ITS BLASTIC PHASE

, 1983
Nakayuki Kitagawa
openalex   +2 more sources

Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia.

Cancer Cell, 2012
Bin Zhang, Yinwei Ho, Qin Huang, Takahiro Maeda, A. Lin, Sung-Uk Lee, A. Hair, T. Holyoake, C. Huettner, R. Bhatia   +9 more
semanticscholar   +1 more source

Extracellular vesicles enhance the in vivo antitumor effects of millettia species-derived compounds in chronic myelogenous leukemia therapy. [PDF]

Front Chem
Xie Z, Cheng X, Mao J, Zhu Y, Li L, Mei Z.   +5 more
europepmc   +1 more source

Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin

, 2018
Chu Zhang, Lu-Ying Guo, Dan Mu, Jianhua Gong, Jing Chen   +4 more
openalex   +2 more sources

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

Blood, 2003
N. Donato, J. Wu, J. Stapley, G. Gallick, Hui-Kuan Lin, R. Arlinghaus, M. Talpaz   +6 more
semanticscholar   +1 more source

Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection. [PDF]

Biomicrofluidics
Pinnenti M, Sami MA, Hassan U.
europepmc   +1 more source